(Q28336736)

https://api.crossref.org/works/10.1136/JNNP.38.4.331

16 September 2023

3

C D Marsden

0 references

author name string

D. Tarsy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1095689

21 August 2022

J. D. Parkes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1095689

full work available at URL

21 August 2022

language of work or name

English

0 references

publication date

April 1975

0 references

https://europepmc.org/articles/PMC491929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1095689

https://europepmc.org/articles/PMC491929?pdf=render

21 August 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1095689

https://syndication.highwire.org/content/doi/10.1136/jnnp.38.4.331

21 August 2022

1 reference

Crossref

DOI

10.1136/JNNP.38.4.331

https://api.crossref.org/works/10.1136/JNNP.38.4.331

Journal of Neurology, Neurosurgery and Psychiatry

16 September 2023

published in

0 references

volume

38

0 references

issue

4

0 references

page(s)

331-5

0 references

cites work

Dystonic reactions in children caused by metoclopramide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

ANTIEMETIC ACTION OF METOCLOPRAMIDE WITH RESPECT TO APOMORPHINE AND HYDERGINE

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Metoclopramide--side effects and safety

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Letter: Dyskinesia after fenfluramine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

Acute drug-induced extrapyramidal syndromes.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=491929

TECHNIC FOR THE STUDY OF THE CENTRAL ACTION OF EMETIC AND ANTIEMETIC POISONS

27 November 2018

1 reference

12 December 2020

PROTECTION EXERCISED BY METOCLOPRAMIDE AGAINST THE VOMITIVE EFFECTS OF COPPER SULFATE

1 reference

12 December 2020

A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone

1 reference

12 December 2020

Letter: Fenfluramine and dyskinesias

1 reference

12 December 2020

Letter: Metaclopramide and prolactin

1 reference

12 December 2020

Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?

1 reference

12 December 2020

Inhibition of the apomorphine gnawing compulsion by amantadine

1 reference

12 December 2020

Gastrointestinal actions of metoclopramide. An experimental study

1 reference

12 December 2020

Clinical and electroencephalographic effects of methoclopramide in psychiatry

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.38.4.331

0 references

PMC publication ID

491929

0 references